… advanced-stage, previously untreated follicular lymphoma; nevertheless, most patients will
have a relapse. Combination immunotherapy with lenalidomide … non-Hodgkin’s lymphoma. …

… Obinutuzumab and lenalidomide (… of lymphoma. We report efficacy and safety results for
the phase 2 GALEN study in previously untreated patients with advanced follicular lymphoma (…

… 15 mg daily for 18 weeks (n = 77), in previously untreated FL patients in need of therapy. …
advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study …

… with low-grade advanced-stage follicular lymphoma (FL) and high tumor burden. … non-Hodgkin
lymphomas were prospectively used for response assessment. The Follicular Lymphoma …

… untreated … lenalidomide plus rituximab (R 2 ) was similarly efficacious to immunochemotherapy
(rituximab plus chemotherapy [R-Chemo]) in patients with previously untreated advanced …

… that lenalidomide plus rituximab (R 2 ) provided similar efficacy to rituximab plus chemotherapy
(R-chemo) in patients with advanced-stage, previously untreated follicular lymphoma (FL)…

… relapsed indolent non-Hodgkin lymphoma. We assessed the efficacy and safety … lenalidomide
plus rituximab in patients with untreated, advanced stage indolent non-Hodgkin lymphoma…

… Lymphoma Group, compared the activity of rituximab vs rituximab plus lenalidomide in
untreated follicular lymphoma … 35/10 phase 2 trial, developed and conducted by the SAKK in …

… lenalidomide and rituximab in pts with untreated, advanced … in pts with untreated indolent
lymphoma. High complete … observed in patients with follicular lymphoma. Randomized studies …

… untreated follicular lymphoma. We aimed to evaluate the safety and activity of the combination
of lenalidomide … treatment of patients with advanced-stage follicular lymphoma: results of …